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To the Editor,
The human normal flora, or microbiota, is 
extensive, both in its absolute quantitative mass and 
in its qualitative diversity. The human intestinal tract 
hosts about 100 trillion microorganisms with at least 
15,000-36,000 bacterial species. The microbiome is 
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The precise etiology of Inflammatory Bowel Disease (IDB) remains unclear and several factors 
are believed to play a role in its development and progression, including the composition of microbial 
communities resident in the gastrointestinal tract.  Human intestinal microbiota are extensive with at least 
15,000-36,000 bacterial species. However, thanks to the new development in sequencing and molecular 
taxonomic methodologies, our understanding of the microbiota population composition, dynamics, and 
ecology has greatly increased. Intestinal microbiota play a critical role in the maintenance of the host 
intestinal barrier homeostasis, while dysbiosis, which involves reduction in the microbiome diversity, can 
lead to progression of inflammatory disorders, such as IBD and colorectal cancer. It is hypothesized that 
fingerprinting characterization of the microbiota community composition is the first step in the study 
of this complex bacterial ecosystem and a crucial step in the targeted therapy. Molecular fingerprinting 
of human gastrointestinal tract microbiota could be performed by different techniques including the 
semi quantitation, 16SrRNA, the DNA- microarray as well as other relatively new methods which were 
developed to study many complex bacterial ecosystems. These techniques provide individual data and 
profiles, using fast and sensitive tools for the high taxonomic level fingerprint of the human intestinal 
microbiota and provide estimation of the relative presence of the microbial target groups within each 
individual. Such personalized information serves as a remarkable and unprecedented opportunity to 
improve targeted medical treatment and probably develop strategies to prevent disease.
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pathogenic toxins for adherence to the intestinal 
epithelium; ii) enhance innate immunity and 
modulate inflammation through their regulated 
signaling pathways via their interaction with Toll-like 
receptors, and iii) enhance intestinal barrier function 
and thus regulate intestinal epithelial homeostasis. 
Moreover, PBs modulate different host cell signaling 
pathways  such as Akt, mitogen-activated protein 
kinases and nuclear-kappa β that could potentially 
mediate intestinal epithelial functions (6). 
Some bacteria, such as Lactobacillus delbruekii 
and Lactobacillus fermentum have been documented 
to ameliorate the inflammatory background. In 
fact, clinical studies on ulcerative colitis patients 
showed significant amelioration of the inflammatory 
state by decreasing the colonic concentrations of 
multiple pro-inflammatory mediators and reducing 
myeloperoxidase activity compared to controls. 
Furthermore, re-establishment of microbial 
homeostasis and manipulation of microbiota in IBD 
treatments, through fecal microbiota transplantation 
of selective bacteria, have been practiced and are 
gaining great interest (7).
Based on this background and the authors 
experimental and clinical experiences, we propose the 
following working hypothesis: the characterization 
of the microbiota community composition is the first 
step in the study of a complex bacterial ecosystem. 
Fingerprinting of IBD patients’ microbiota and its 
mapping, using various molecular techniques, could 
serve as a very crucial and essential step in the targeted 
therapies of IBDs. The metagenomic sequencing 
data provide new insight into the importance of the 
microbial network and its interaction with the host 
genome, which could be therapeutically important, 
as early targeted intervention can restore normal 
flora (8).
MATERIALS AND METHODS
Gut microbiota have been extensively investigated by 
anaerobic culture techniques, but it is now well known 
that culture-based methods provide only an incomplete 
picture of the overall diversity of microbiota (9). 
However, further techniques have been successively 
developed to explore microbial biodiversity. In fact, the 
now considered to be a functional organ involved with 
multiple physiological functions. On the other hand, 
many pathological conditions arise in dysbiosis, 
when the microbiome is drastically altered. IBD 
is one of those conditions which clearly involves 
a breakdown in the healthy interactions between 
the host and the microbiome. A dramatic reduction 
occurs in the phylum Firmicutes and concomitant 
increase in Proteobacteria (1).
The vast majority of bacteria in the human intestinal 
microbiota (>99%) belongs to the six bacterial 
phyla: Firmicutes, Bacteroidetes, Actinobacteria, 
Proteobacteria, Fusobacteria and Verrucomicrobia. 
However, the two dominant divisions are Fermicutes 
(65%) and Bacteroidetes (25%) of total microbiota. 
The intestinal microbiota of each individual have 
a specific complement of hundreds of genera and 
thousands of bacterial species (1). Conventional 
microbiological techniques fail to give a detailed 
inventory of the normal microbiota, but the 
development of recent high-throughput sequencing 
and high level molecular taxonomic methodologies 
have greatly increased our understanding of the 
microbiota population composition, dynamics, and 
ecology (2). 
The composition of intestinal flora is remarkably 
stable at different anatomic locations along the gut, 
but absolute numbers vary greatly, ranging from 
1011 cells/g in the ascending colon to 107-108 in the 
distal ileum, and 102 to 103 in the proximal ileum and 
jejunum (1, 3). 
It is also well documented that intestinal 
microbiota play a critical role in the maintenance 
of host intestinal barrier homeostasis by exerting 
beneficial effects on diverse physiological intestinal 
functions while dysbiosis can lead to progression of 
inflammatory disorders such as inflammatory bowel 
disease (IBD) and colorectal cancer (CRC) (4, 5). 
A well balanced gut microbiota promotes the 
health of colocytes through the production of a 
variety of important compounds and the correct 
modulation of the immune system (2). 
Along this line, probiotics (PBs) have been used, 
and some studies have suggested three mechanisms 
for their action in IBD therapy they may: i) block 
the pathogenic bacterial effect and compete with 
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need for any genomic sequence information. 
v. Real time polymerase chain reaction (PCR) is a 
powerful method for amplyfing particular segments of 
DNA, distinct from cloning and propagation within the 
host cell; this technique uses the oligonucleotide as a 
primer and elongates its 3’ end to generate an extended 
region of double stranded DNA. 
vi. Human Intestinal Tract Chip (HIT chip) is a 
16SrRNA gene-based diversity microarray which was 
developed and validated for the characterisation of 
human gut microbiota. It is an oligonucleotide microarray 
commonly used for phylogenetic profiling  (13, 14). 
RESULTS
Thanks to such advances of the 16S ribosomal 
RNA genomic sequencing, a decrease in Bacteroides 
and Firmicutes numbers in the colon and an increase 
in Enterobacteriaceae, such as adherent-invasive E. 
coli and other Proteobacteria, have been detected in 
Crohn’s disease (5, 12). 
Moreover, the HIT Chip technology, which is 
a 16SrRNA gene based diversity for phylogenetic 
profiling of human intestinal tract communities (15), 
and the pyrosequencing have been developed to 
serve as a more economic sequencing approach than 
high-coverage amplicon sequencing, to study many 
complex bacterial ecosystems. 
The data emanating from many techniques 
intersect, and could sometimes be complementary in 
determining microbial community profiling. Using 
the HIT Chip hybridization method has shown 
strong concordance with the pyrosequencing-based 
profiling data and sequencing of 16S rRNA gene 
clone libraries (4, 16). 
In brief, microbiota fingerprinting in IBDs is 
a feasible and useful  cost effective approach that 
could lead to a targeted therapy or even prevention 
through supplying missing bacterial species through 
probiotics or other.
DISCUSSION
It is well established that inflammatory 
pathologies affecting the gastrointestinal tract are 
narrowly correlated to dismicrobism (2).  
composition of the adult intestinal microbiota has been 
determined in 3 large scale 16SrRNA sequence surveys. 
Other methods, such as the High Taxonomic Fingerprint 
(HTF-Microbi.Array) and the Ligase Detection Reaction-
Universal Array (LDR-UA) approach have been recently 
extensively used. The HTF Microbi-Array enables specific 
detection and approximate relative quantification of 16S 
rRNA from 30 phylogenetically-related groups of human 
intestinal microbiota. This technique was applied to adult 
human subjects with high reproducibility of the high level 
taxonomic microbiota fingerprint for each individual (8, 
10-12). Other techniques are also being employed such as: 
i. Denaturing/temperature gradient gel electrophoresis 
(D/TGGE) which is used to separate proteins or nucleic 
acids (DNA and RNA) across a temperature gradient. 
TGGE is based on the principles that the structure of 
proteins and DNA changes with temperature and that these 
changes can be characterized by their movement through a 
gel. It is often associated with Polymerase Chain Reaction 
(PCR) analysis.
ii. The strand conformation polymorphism (SSCP) 
analysis is a simple and sensitive technique for mutation 
detection and genotyping. The principle of SSCP analysis 
is based on the fact that single stranded DNA has a defined 
conformation. Altered conformation due to a single base 
change in the sequence can cause Single-Stranded DNA to 
migrate differently under a non-denaturing electrophoresis 
conditions.
iii. Fluorescent in situ hybridization (FISH) is a 
cytogenetic technique which uses fluorescent probes 
binding parts of the chromosomes to show a high degree 
of sequence complementarity. This technique provides a 
novel way for researchers to visualize and map the genetic 
material in an individual cell or bacteria, including specific 
genes or portions of genes. 
iv. Terminal restriction fragment length polymorphism 
(T-RFLP) analysis is used to study complex microbial 
communities based on variation in the 16SrRNA gene. This 
technique can be used to examine microbial community 
structure and community dynamics in response to changes 
in different environmental parameters or to study bacterial 
populations in natural habitats. It has been applied to 
the study of complex microbial communities in diverse 
environments, such as soil, marine, oral bacterial flora in 
saliva in healthy subjects versus patients. RFLP is culture 
independent, rapid, sensitive and reproducible without the 
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different sequence features for patterns that are 
unique to each individual. To do so, they combined 
stable and distinguishing sequence features from 
the individual’s initial microbiome samples and 
compared them both to samples from the same 
individuals collected at follow-up visits and samples 
collected from control group individuals. Researchers 
found that the “codes” were unique among hundreds 
of participants and that also a number of them (more 
than 80%) remained stable over the sampling period 
of one year. In some ways, it could be said that they 
were able to identify “microbiome fingerprints”. In 
brief, there are many aspects that are the same for 
many people but the existing differences are enough 
to characterise each individual.
Nowadays, it is possible to perform a 
comprehensive microbiota assessment of an 
individual, including  DNA and RNA sequence, 
and at least some characterization of  proteome, 
microbiome and epigenome. It has become 
abundantly clear that each of us actually has a one-
of-a-kind biological content. Analysing the large 
volume of microbial gut, based on the whole genome 
sequencing (WGS) and preparing high quality 
representative RNAs for sequencing to generate 
metatranscriptome along with the establishment of 
the gut microbial interaction network model, is a 
major challenge (12). 
Well beyond the allure of the matchless fingerprint 
or snowflake concept, these singular individual data 
and information set up a remarkable and unprecedented 
opportunity to improve medical treatment and develop 
preventive strategies for disease (13).
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